71.47
price down icon4.86%   -3.65
after-market Dopo l'orario di chiusura: 71.57 0.10 +0.14%
loading

Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - 0.0735
Operating Expenses
0.39%
3.2343
3.2218 11.07 1.5749 1.7888
Operating Income/Loss
0.39%
-3.2343
-3.2218 -11.07 -1.5749 -1.7888
Income/Loss From Continuing Operations Before Tax
6.53%
-2.4535
-2.625 -10.92 -1.3043 -1.7153
Income/Loss From Continuing Operations After Tax
6.53%
-2.4535
-2.625 -10.93 -1.3043 -1.7153
Net Income/Loss
6.53%
-2.4535
-2.625 -10.93 -1.3043 -1.7153
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.15%
6.9981
6.9874 0.3709 3.5204 17.51
Basic Earnings Per Share
7.89%
-0.35
-0.38 -2.75 -0.37 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.38
price down icon 0.39%
$97.03
price down icon 1.63%
$31.35
price down icon 0.70%
$92.23
price down icon 1.68%
biotechnology ONC
$304.31
price down icon 2.05%
$200.67
price up icon 1.90%
Capitalizzazione:     |  Volume (24 ore):